- Home
- SFBC vs CLLS Comparison
SFBC vs CLLS Comparison
Compare SFBC & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFBC
- CLLS
- Stock Information
- Founded
- SFBC 1953
- CLLS 1999
- Country
- SFBC United States
- CLLS France
- Employees
- SFBC N/A
- CLLS N/A
- Industry
- SFBC Savings Institutions
- CLLS Biotechnology: Pharmaceutical Preparations
- Sector
- SFBC Finance
- CLLS Health Care
- Exchange
- SFBC Nasdaq
- CLLS Nasdaq
- Market Cap
- SFBC 127.6M
- CLLS 148.1M
- IPO Year
- SFBC N/A
- CLLS 2007
- Fundamental
- Price
- SFBC $50.56
- CLLS $1.53
- Analyst Decision
- SFBC
- CLLS Buy
- Analyst Count
- SFBC 0
- CLLS 3
- Target Price
- SFBC N/A
- CLLS $7.00
- AVG Volume (30 Days)
- SFBC 1.2K
- CLLS 113.6K
- Earning Date
- SFBC 01-29-2025
- CLLS 11-04-2024
- Dividend Yield
- SFBC 1.50%
- CLLS N/A
- EPS Growth
- SFBC N/A
- CLLS N/A
- EPS
- SFBC 1.82
- CLLS N/A
- Revenue
- SFBC $35,777,000.00
- CLLS $36,042,000.00
- Revenue This Year
- SFBC N/A
- CLLS $387.77
- Revenue Next Year
- SFBC N/A
- CLLS $11.14
- P/E Ratio
- SFBC $27.76
- CLLS N/A
- Revenue Growth
- SFBC N/A
- CLLS 46.96
- 52 Week Low
- SFBC $39.15
- CLLS $1.41
- 52 Week High
- SFBC $55.99
- CLLS $3.38
- Technical
- Relative Strength Index (RSI)
- SFBC 32.66
- CLLS 45.06
- Support Level
- SFBC $51.25
- CLLS $1.51
- Resistance Level
- SFBC $52.13
- CLLS $1.62
- Average True Range (ATR)
- SFBC 0.39
- CLLS 0.09
- MACD
- SFBC -0.10
- CLLS 0.01
- Stochastic Oscillator
- SFBC 0.00
- CLLS 29.17
About SFBC Sound Financial Bancorp Inc.
Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.